However, given the importance of this region in regulating cdk activity, the presence of this mutation in a cancer cell line, the constraints imposed by proline in terms of peptide backbone angles and the non-conservative nature of the substitution involved, we undertook to characterise the properties of this P45L cdk2 to determine if they could be contributory to deregulated cell cycle control. This evidence concerns the gene CDK2 and cancer.